I had a quick look (so take what I say with a grain of salt) and I'm not a fan. High debt ~24b, twice as much as their market cap. Gross margin nearly 70% which is really good and they are cash flow positive, also good. But they spend almost $400m per quarter to service those debts which almost eats up all their free cash flow so I'm not sure where this is going.
Icahn's average cost is $25 per CNBC so not a lot lower than current price. I'm sure he sees great value in this but I'm too stupid to find anything attractive.
Upcoming spinoff of the eye care division - potentially good. Selling non core business to pay down debt - also good. Enough for me to follow Icahn and buy into this company? Hell no